SLC7A11 and hepatocellular carcinoma: To evaluate the associations of SLC7A11 expression with various clinicopathological characteristics of HCC patients, we divided 373 HCC patients into high (n = 187) and low (n = 186) expression groups according to the median of SLC7A11 expression levels (63.54).